Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.CON.RES.342
H.CON.RES.342: Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest.
About This Bill
- This bill was introduced in the 110th Congress
- This bill is primarily about health
- Introduced May 6, 2008
- Latest Major Action May 7, 2008
Bill Sponsor
Bill Cosponsors
58 (25 Democrats, 34 Republicans)
Bill Summary
Calls for the Food and Drug Administration (FDA) to reverse its policy that aims to eliminate patient access to compounded medications containing estriol prescribed by physicians.
(Source: Library of Congress)
Bill Actions
Date | Description |
---|---|
Referred to the House Committee on Energy and Commerce.
|
|
Referred to the Subcommittee on Health.
|
|
May 6, 2008 |
Introduced in the House by Mike Ross (D-Ark.) |